SERIES B COMMON SHARE PURCHASE WARRANTAbvc Biopharma, Inc. • July 28th, 2021 • Pharmaceutical preparations • New York
THIS SERIES B COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ________ __, 20261 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ABVC BioPharma, Inc., a Nevada corporation (the “Company”), up to ______ Common Shares (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and the Depository Trust Company or its nominee (“DTC”) shall initially be the sole registered holder of this Warrant, subject to a Holder’s right to
ABVC BIOPHARMA, INC. and VSTOCK TRANSFER, LLC as Warrant Agent Warrant Agency Agreement Dated as of ___________, 2021 WARRANT AGENCY AGREEMENTWarrant Agency Agreement • July 28th, 2021 • Abvc Biopharma, Inc. • Pharmaceutical preparations • New York
WARRANT AGENCY AGREEMENT, dated as of __________, 20__ (“Agreement”), between ABVC BioPharma, Inc. , a Nevada corporation (the “Company”), and VStock Transfer, LLC, a _______ limited liability trust company (the “Warrant Agent” or “VStock”).
